Progyny, Inc. (PGNY)
NASDAQ • Healthcare
Last close at October 26, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, Progyny, Inc. keeps $8 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 4
in 8 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Next report — what to expect
Progyny, Inc. (PGNY) reports earnings on November 5, 2026. Wall Street is looking for consensus EPS of $0.313 on consensus revenue of $340.6 million; as trailing context, revenue grew +5.3% year over year last quarter. PGNY has beaten EPS in 5 of 8 most recent quarters.
About Progyny, Inc.
Progyny, Inc. provides fertility and family-building benefits in the healthcare coverage market, serving employers in the United States through a fertility benefits plan, related pharmacy coverage, and member support. The company, listed on NASDAQ as PGNY, generated $1.3 billion in revenue in FY2025.
Today's Snapshot
PGNY closed 2.9% lower at 28.13, while its sector was flat. Progyny reported a study showing over 70% of members improved menopause symptoms through its care program. Earnings are due from PGNY on 4 November.
Trading Volume
Below 10d avg (848.3K)
631.7K
vs S&P 500 Today
Strong Underperformance
-3.59%
Updated: October 26, 2026 at 20:11 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$24.95 - $28.12Buy
- RSI (14)55.46Neutral
- Stochastic %K (14, 3, 3)85.76Sell
- MACD Level (12, 26)0.54Buy
Peers & Related Assets
Get premium market insights delivered directly to your inbox.